Marizyme (MRZM) Issued Coverage off FDA Feedback for Pediatric Stroke Treatment

(NEW YORK)– Marizyme, Inc. (OTC: MRZM), a biotechnology company focused on its clinically-tested and patented use of protease therapeutic platform called Krillase™. FDA Feedback Regarding Pediatric Stroke The Company recently announced that they have received FDA feedback regarding their development plan for Krillase™ (MB102) in pediatric stroke. In preparation for initiating development activities for MB102, […]

Share
Continue Reading

Real Brands (RLBD) Added to Cannabis Investor Watch List on Brand Portfolio Potential

(NEW YORK)— Real Brands, Inc. (OTC:RLBD) was added to Ludlow Research cannabis watch list as a select small cap cannabis play investors should add to their radar. RLBD recently announced they had acquired the trademarks Humboldt Brands®, Hemp-Aid® and HempAid®, which expands the company’s brand portfolio for future offerings of CBD products. Real Brands is […]

Share
Continue Reading